A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Clinical Trial ID NCT00320216

PubWeight™ 5.95‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00320216

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007 5.39
2 Potential role of ustekinumab in the treatment of chronic plaque psoriasis. Biologics 2010 0.78
Next 100